SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Icebrg10/9/2007 5:55:31 PM
   of 10280
 
.
.
.

However, with total annual sales in Europe stagnating over 2005 and 2006 at approximately $100 million, the US market is the main growth opportunity with potential annual sales of up to $570 million, which makes this launch an important step forward. Across the seven major markets (US, France, Germany, Italy, Spain, the UK and Japan), the drug is set to emerge as the new market leader in the oral antihistamine sector after Zyrtec's patent expiry, with predicted total annual peak sales of $720 million in 2012.

tradingmarkets.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News